Globoid Cell Leukodystrophy Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: G954A97B90FCEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Globoid Cell Leukodystrophy Treatment in Global, including the following market information:

Global Globoid Cell Leukodystrophy Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Globoid Cell Leukodystrophy Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

RND-001 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Globoid Cell Leukodystrophy Treatment include Commence Bio Inc, Kyorin Pharmaceutical Co Ltd, Novartis AG and Nuo Therapeutics Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Globoid Cell Leukodystrophy Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Globoid Cell Leukodystrophy Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Globoid Cell Leukodystrophy Treatment Market Segment Percentages, by Type, 2021 (%)

• RND-001
• CMB-200
• DUOC-01
• Others

Global Globoid Cell Leukodystrophy Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Globoid Cell Leukodystrophy Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Research Center

Global Globoid Cell Leukodystrophy Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Globoid Cell Leukodystrophy Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Globoid Cell Leukodystrophy Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Globoid Cell Leukodystrophy Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Commence Bio Inc
• Kyorin Pharmaceutical Co Ltd
• Novartis AG
• Nuo Therapeutics Inc

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Globoid Cell Leukodystrophy Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Globoid Cell Leukodystrophy Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GLOBOID CELL LEUKODYSTROPHY TREATMENT OVERALL MARKET SIZE

2.1 Global Globoid Cell Leukodystrophy Treatment Market Size: 2021 VS 2028
2.2 Global Globoid Cell Leukodystrophy Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Globoid Cell Leukodystrophy Treatment Players in Global Market
3.2 Top Global Globoid Cell Leukodystrophy Treatment Companies Ranked by Revenue
3.3 Global Globoid Cell Leukodystrophy Treatment Revenue by Companies
3.4 Top 3 and Top 5 Globoid Cell Leukodystrophy Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Globoid Cell Leukodystrophy Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Globoid Cell Leukodystrophy Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Globoid Cell Leukodystrophy Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Globoid Cell Leukodystrophy Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Globoid Cell Leukodystrophy Treatment Market Size Markets, 2021 & 2028
  4.1.2 RND-001
  4.1.3 CMB-200
  4.1.4 DUOC-01
  4.1.5 Others
4.2 By Type - Global Globoid Cell Leukodystrophy Treatment Revenue & Forecasts
  4.2.1 By Type - Global Globoid Cell Leukodystrophy Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Globoid Cell Leukodystrophy Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Globoid Cell Leukodystrophy Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Globoid Cell Leukodystrophy Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Research Center
5.2 By Application - Global Globoid Cell Leukodystrophy Treatment Revenue & Forecasts
  5.2.1 By Application - Global Globoid Cell Leukodystrophy Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Globoid Cell Leukodystrophy Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Globoid Cell Leukodystrophy Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Globoid Cell Leukodystrophy Treatment Market Size, 2021 & 2028
6.2 By Region - Global Globoid Cell Leukodystrophy Treatment Revenue & Forecasts
  6.2.1 By Region - Global Globoid Cell Leukodystrophy Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Globoid Cell Leukodystrophy Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Globoid Cell Leukodystrophy Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Globoid Cell Leukodystrophy Treatment Revenue, 2017-2028
  6.3.2 US Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
  6.3.3 Canada Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
  6.3.4 Mexico Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Globoid Cell Leukodystrophy Treatment Revenue, 2017-2028
  6.4.2 Germany Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
  6.4.3 France Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
  6.4.4 U.K. Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
  6.4.5 Italy Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
  6.4.6 Russia Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
  6.4.8 Benelux Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Globoid Cell Leukodystrophy Treatment Revenue, 2017-2028
  6.5.2 China Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
  6.5.3 Japan Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
  6.5.4 South Korea Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
  6.5.6 India Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Globoid Cell Leukodystrophy Treatment Revenue, 2017-2028
  6.6.2 Brazil Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
  6.6.3 Argentina Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Globoid Cell Leukodystrophy Treatment Revenue, 2017-2028
  6.7.2 Turkey Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
  6.7.3 Israel Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028
  6.7.5 UAE Globoid Cell Leukodystrophy Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Commence Bio Inc
  7.1.1 Commence Bio Inc Corporate Summary
  7.1.2 Commence Bio Inc Business Overview
  7.1.3 Commence Bio Inc Globoid Cell Leukodystrophy Treatment Major Product Offerings
  7.1.4 Commence Bio Inc Globoid Cell Leukodystrophy Treatment Revenue in Global Market (2017-2022)
  7.1.5 Commence Bio Inc Key News
7.2 Kyorin Pharmaceutical Co Ltd
  7.2.1 Kyorin Pharmaceutical Co Ltd Corporate Summary
  7.2.2 Kyorin Pharmaceutical Co Ltd Business Overview
  7.2.3 Kyorin Pharmaceutical Co Ltd Globoid Cell Leukodystrophy Treatment Major Product Offerings
  7.2.4 Kyorin Pharmaceutical Co Ltd Globoid Cell Leukodystrophy Treatment Revenue in Global Market (2017-2022)
  7.2.5 Kyorin Pharmaceutical Co Ltd Key News
7.3 Novartis AG
  7.3.1 Novartis AG Corporate Summary
  7.3.2 Novartis AG Business Overview
  7.3.3 Novartis AG Globoid Cell Leukodystrophy Treatment Major Product Offerings
  7.3.4 Novartis AG Globoid Cell Leukodystrophy Treatment Revenue in Global Market (2017-2022)
  7.3.5 Novartis AG Key News
7.4 Nuo Therapeutics Inc
  7.4.1 Nuo Therapeutics Inc Corporate Summary
  7.4.2 Nuo Therapeutics Inc Business Overview
  7.4.3 Nuo Therapeutics Inc Globoid Cell Leukodystrophy Treatment Major Product Offerings
  7.4.4 Nuo Therapeutics Inc Globoid Cell Leukodystrophy Treatment Revenue in Global Market (2017-2022)
  7.4.5 Nuo Therapeutics Inc Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Globoid Cell Leukodystrophy Treatment Market Opportunities & Trends in Global Market
Table 2. Globoid Cell Leukodystrophy Treatment Market Drivers in Global Market
Table 3. Globoid Cell Leukodystrophy Treatment Market Restraints in Global Market
Table 4. Key Players of Globoid Cell Leukodystrophy Treatment in Global Market
Table 5. Top Globoid Cell Leukodystrophy Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Globoid Cell Leukodystrophy Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Globoid Cell Leukodystrophy Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Globoid Cell Leukodystrophy Treatment Product Type
Table 9. List of Global Tier 1 Globoid Cell Leukodystrophy Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Globoid Cell Leukodystrophy Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Globoid Cell Leukodystrophy Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Globoid Cell Leukodystrophy Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Globoid Cell Leukodystrophy Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Globoid Cell Leukodystrophy Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Globoid Cell Leukodystrophy Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Globoid Cell Leukodystrophy Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Commence Bio Inc Corporate Summary
Table 31. Commence Bio Inc Globoid Cell Leukodystrophy Treatment Product Offerings
Table 32. Commence Bio Inc Globoid Cell Leukodystrophy Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Kyorin Pharmaceutical Co Ltd Corporate Summary
Table 34. Kyorin Pharmaceutical Co Ltd Globoid Cell Leukodystrophy Treatment Product Offerings
Table 35. Kyorin Pharmaceutical Co Ltd Globoid Cell Leukodystrophy Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Novartis AG Corporate Summary
Table 37. Novartis AG Globoid Cell Leukodystrophy Treatment Product Offerings
Table 38. Novartis AG Globoid Cell Leukodystrophy Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Nuo Therapeutics Inc Corporate Summary
Table 40. Nuo Therapeutics Inc Globoid Cell Leukodystrophy Treatment Product Offerings
Table 41. Nuo Therapeutics Inc Globoid Cell Leukodystrophy Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Globoid Cell Leukodystrophy Treatment Segment by Type in 2021
Figure 2. Globoid Cell Leukodystrophy Treatment Segment by Application in 2021
Figure 3. Global Globoid Cell Leukodystrophy Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Globoid Cell Leukodystrophy Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Globoid Cell Leukodystrophy Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Globoid Cell Leukodystrophy Treatment Revenue in 2021
Figure 8. By Type - Global Globoid Cell Leukodystrophy Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Globoid Cell Leukodystrophy Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Globoid Cell Leukodystrophy Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Globoid Cell Leukodystrophy Treatment Revenue Market Share, 2017-2028
Figure 12. US Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Globoid Cell Leukodystrophy Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Globoid Cell Leukodystrophy Treatment Revenue Market Share, 2017-2028
Figure 24. China Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Globoid Cell Leukodystrophy Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Globoid Cell Leukodystrophy Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Globoid Cell Leukodystrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Commence Bio Inc Globoid Cell Leukodystrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Kyorin Pharmaceutical Co Ltd Globoid Cell Leukodystrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis AG Globoid Cell Leukodystrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Nuo Therapeutics Inc Globoid Cell Leukodystrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)